Head-to-head · Cost-Efficiency Index
WeightCare vs Metaboost Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WeightCare
Cost-first shoppers who want a genuine month-to-month plan covering the full dose range, without a multi-month prepay commitment.
Visit WeightCareMetaboost Rx
Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote.
Visit Metaboost RxThe verdict
WeightCare and Metaboost Rx tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with WeightCare (ranked #352, a hair above #359) — Cost-first shoppers who want a genuine month-to-month plan covering the full dose range, without a multi-month prepay commitment. But Metaboost Rx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs WeightCare.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WeightCare | Metaboost Rx |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | $399/mo (all doses, compounded) | $249/mo (starting dose, compounded) |
| Tirzepatide / mo | $499/mo (all doses, prepay plan, compounded) | $299/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $4,788 | $2,988 |
| Tirzepatide / yr (modeled) | $5,988 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #352 | #359 |
WeightCare
54/100Where the value is
- True month-to-month plans exist with no prepay commitment, covering the full published dose range for both drugs
- PCAB-accredited, FDA-registered compounding pharmacies explicitly claimed (industry-recognized quality signal, though the specific pharmacy is not named)
- Cancellation requires only 7-day notice before renewal
The tradeoffs
- The cheapest advertised per-month prices ($215 sema, $275 tirz) require a full 6-month prepay ($1,290 / $1,650 up front) and cap you below the drug's top dose — going higher costs more via a separate High Dose plan
- No LegitScript certification found anywhere on the site
Regulatory note: the FDA issued a warning letter to Weightless Medical LLC dba WeightCare in February 2026. We still list and link to WeightCare; you should know the letter is on the public record before you decide.
Metaboost Rx
54/100Where the value is
- Publishes at least headline starting prices on the homepage, unlike some peers that hide all numbers
- '$0 if not approved' guarantee reduces risk of a wasted consultation fee
- Offers a microdose GLP-1 tier alongside standard semaglutide/tirzepatide
The tradeoffs
- Homepage price and product-page pricing don't match up -- dose tiers and confirmed rates are never shown together
- No named medical director or compounding pharmacy partner disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.